Results 121 to 130 of about 21,238,241 (185)

端粒酶和CYFRA 21-1测定对良恶性胸腔积液的诊断价值

open access: yesZhongguo shiyan zhenduanxue, 2006
目的研究胸腔积液端粒酶活性及CYFRA21-1在良、恶性胸腔积液中的诊断价值。方法用聚合酶链反应—酶联免疫吸附分析法(PCR-ELISA)检测胸腔积液端粒酶活性,用免疫放射分析法(IRA)测定胸液CYFRA21-1水平,并与细胞学诊断结果进行比较,根据最终的诊断结果,67例患者分成2组:(1)非恶性胸腔积液35例;(2)恶性胸腔积液32例。结果非恶性胸腔积液中端粒酶阳性2例(5.7%),恶性胸腔积液阳性26例(81.3%),端粒酶活性测定诊断恶性胸腔积液的灵敏度为81.3%,特异度94%,正确率93 ...
魏仲航, 杨杰, 魏延君
doaj  

Clinical Value of Serum HMGB1 Levels in Early Detection of Recurrent Squamous Cell Carcinoma of Uterine Cervix: Comparison with Serum SCCA, CYFRA21-1, and CEA Levels

open access: yes, 2009
Aim To evaluate the clinical value of serum high mobility group box chromosomal protein 1 (HMGB1) levels in making the early diagnosis of recurrent cervical squamous cell carcinomas (CSCC) and compare it with the value of serum squamous cell ...
Ma, Zhifang   +17 more
core  

CA-125, CA-153, and CYFRA21-1 as clinical indicators in male lung cancer with ocular metastasis. [PDF]

open access: yesJ Cancer, 2020
Li B   +10 more
europepmc   +1 more source

An Investigation of the Availability of CYFRA21-1 as a Tumor Marker in Head and Neck Cancer.

open access: yesPractica Oto-Rhino-Laryngologica, 1997
Hideyuki KAWAUCHI   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy